MXVIX
Price
$42.14
Change
-$1.17 (-2.70%)
Updated
Oct 10 closing price
Net Assets
8.64B
VTSAX
Price
$156.59
Change
-$4.39 (-2.73%)
Updated
Oct 10 closing price
Net Assets
2.02T
Interact to see
Advertisement

MXVIX vs VTSAX

Header iconMXVIX vs VTSAX Comparison
Open Charts MXVIX vs VTSAXBanner chart's image
Empower S&P 500® Index Investor
Price$42.14
Change-$1.17 (-2.70%)
VolumeN/A
Net Assets8.64B
Vanguard Total Stock Mkt Idx Adm
Price$156.59
Change-$4.39 (-2.73%)
VolumeN/A
Net Assets2.02T
MXVIX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
MXVIX vs. VTSAX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXVIX is a Hold and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.02T vs. MXVIX (8.64B). VTSAX pays higher dividends than MXVIX: VTSAX (1.13) vs MXVIX (0.41). MXVIX was incepted earlier than VTSAX: MXVIX (22 years) vs VTSAX (25 years). MXVIX (0.49) is less costly to investors than VTSAX (0.04). MXVIX (2.00) and VTSAX (2.00) have comparable annual turnover. MXVIX has a lower initial minimum investment than VTSAX: MXVIX (0) vs VTSAX (3000). MXVIX (17.02) and VTSAX (16.58) have marching annual gain over last year. VTSAX return over 5 years is better than : 87.23 vs. MXVIX (72.96).
MXVIXVTSAXMXVIX / VTSAX
Total Expense Ratio0.490.041,225%
Annual Report Gross Expense Ratio0.490.041,225%
Fund Existence22 years25 years-
Gain YTD15.18714.222107%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.64B2.02T0%
Annual Yield % from dividends0.411.1337%
Returns for 1 year17.0216.58103%
Returns for 3 years81.9284.4397%
Returns for 5 years72.9687.2384%
Returns for 10 years162.93233.6470%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIUIX26.64N/A
N/A
Federated Hermes International Equity IS
JFNCX62.53N/A
N/A
Janus Henderson Global Life Sciences C
JOEIX15.02N/A
N/A
JOHCM Emerging Markets Opps Advisor
BHCHX19.58N/A
N/A
Baron Health Care Instl
RLBBX38.01-0.61
-1.58%
American Funds American Balanced R2